INTEST Corp Files 8-K on Financial Results and Regulation FD Disclosure

TL;DR

**INTEST Corp just dropped an 8-K about their financials and a Regulation FD disclosure, so keep an eye out for details.**

AI Summary

INTEST Corporation filed an 8-K on February 29, 2024, to report on its results of operations and financial condition, and to make a Regulation FD disclosure. The filing indicates that the company, incorporated in Delaware with IRS number 22-2370659, is headquartered at 804 East Gate Drive, Suite 200, Mt. Laurel, New Jersey 08054. This report is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Why It Matters

This filing provides an update on INTEST Corporation's financial performance and ensures fair disclosure of material information to the public, which can influence investor decisions.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial results and Regulation FD, not indicating any immediate high-risk events.

Key Players & Entities

• INTEST Corporation (company) — Registrant
• Delaware (company) — State of Incorporation
• 22-2370659 (dollar_amount) — I.R.S. Employer Identification No.
• 804 East Gate Drive, Suite 200, Mt. Laurel, New Jersey 08054 (company) — Address of Principal Executive Offices
• February 29, 2024 (company) — Date of Report

FAQ

Key Financial Figures

• $0.01 — h Registered Common Stock , par value $0.01 per share INTT NYSE American Indica

Filing Documents

• intt20240229_8k.htm (8-K) — 29KB
• ex_633206.htm (EX-99.1) — 16KB
• intest01.jpg (GRAPHIC) — 8KB
• intest02.jpg (GRAPHIC) — 5KB
• 0001437749-24-006147.txt ( ) — 197KB
• intt-20240229.xsd (EX-101.SCH) — 3KB
• intt-20240229_def.xml (EX-101.DEF) — 11KB
• intt-20240229_lab.xml (EX-101.LAB) — 15KB
• intt-20240229_pre.xml (EX-101.PRE) — 11KB
• intt20240229_8k_htm.xml (XML) — 3KB

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition On February 29, 2024, inTEST Corporation (the "Company") issued a press release regarding its preliminary financial results for the fourth quarter ended December 31, 2023.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On February 29, 2024, the Company issued a press release announcing that it will delay the issuance of its fourth quarter and full year 2023 earnings release and investor conference call, previously scheduled for March 1, 2024, as the Company requires additional time to complete the year-end audit and review process. The information furnished under Items 2.02 and 7.01 including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under such section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release Dated February 29, 2024. 104 Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. inTEST CORPORATION By: /s/ Duncan Gilmour Duncan Gilmour Chief Financial Officer, Treasurer and Secretary Date: February 29, 2024

View Full Filing

View this 8-K filing on SEC EDGAR